Energy Transfer between AGuIX Nanoparticles and Photofrin under Light or X-ray Excitation for PDT Applications

Batoul Dhaini, Philippe Arnoux, Joel Daouk, Francois Lux, Olivier Tillement, Agnes Hagege, Tayssir Hamieh, Gal Shafirstein, Celine Frochot*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Photodynamic therapy is an accepted therapy cancer treatment. Its advantages encourage researchers to delve deeper. The use of nanoparticles in PDT has several advantages including the passive targeting of cancer cells. The aim of this article is to evaluate the effectiveness of AGuIX nanoparticles (activation and guiding of irradiation by X-ray) in the presence or absence of a photosensitizer, Photofrin, under illumination of 630 nm or under X-ray irradiation. The goal is to improve local tumor control by combining PDT with low-dose-X-ray-activated NPs in the treatment of locally advanced metastatic lung cancer. The study of the energy transfer, which occurs after excitation of Gd/Tb chelated in AGuIX in the presence of Photofrin, was carried out. We could observe the formation of singlet oxygen after the light or X-ray excitation of Gd and Tb that was not observed for AGuIX or Photofrin alone, proving that it is possible to realize energy transfer between both compounds.
Original languageEnglish
Article number1033
Number of pages13
JournalPharmaceuticals
Volume17
Issue number8
DOIs
Publication statusPublished - 1 Aug 2024

Keywords

  • PDT
  • Photofrin
  • FRET
  • cancer
  • AGuIX nanoparticles
  • SINGLET OXYGEN
  • PHOTODYNAMIC THERAPY
  • RADIATION
  • STATE

Fingerprint

Dive into the research topics of 'Energy Transfer between AGuIX Nanoparticles and Photofrin under Light or X-ray Excitation for PDT Applications'. Together they form a unique fingerprint.

Cite this